Skip to content
AlternativeMed

Glucose Monitoring as a Nutrition Input

How continuous glucose monitor data is used as an input for nutrition research and apps, what the FDA clearance covers, and what the evidence does and does not show for people without diabetes.

Content last updated . This page has not been medically reviewed.

Quick answer
A continuous glucose monitor (CGM) is a small wearable sensor that estimates sugar levels in fluid under the skin and sends readings to a phone. In diabetes care it is a recognized tool. As a nutrition input for people without diabetes, the research is newer and narrower: glucose data has been used to compare how people respond to the same foods. It has not been shown to improve long-term health in people without diabetes. This page explains the evidence and gives no food or glucose targets. Labels: approved device (specific indication), promising but limited, insufficient evidence.

What the research used glucose data for

  • Showing that responses to identical food vary. In an 800-person cohort, glucose responses to identical meals varied widely. [2] In the UK PREDICT 1 study (1,002 people), the variation (coefficient of variation) in blood glucose after identical meals was 68%. [3] A correction notice exists for that paper. [4]
  • Showing that "normal" glucose is not flat. In a CGM study, even people considered normoglycemic by standard measures showed high glucose variability, with levels reaching prediabetic and diabetic ranges 15% and 2% of the time. [5] What this means for health is unknown; the authors framed it as a research finding about patterns, not a diagnosis. Compare Glucose "Spikes" and Oversimplified Claims.
  • Feeding algorithms. The glucose-prediction models and the trials built on them are covered on Personalized Glycemic Predictions.

What has been shown in trials

Trials that used CGM as part of a guided diet were done mostly in people with prediabetes or type 2 diabetes. A 225-person prediabetes trial found the CGM-and-algorithm diet reduced time above 140 mg/dL and HbA1c somewhat more than a Mediterranean diet, with a mean HbA1c change of -0.16% versus -0.08%. [6] A 23-person crossover pilot in newly diagnosed type 2 diabetes found lower glucose measures on the personalized diet over two weeks. [7] These are promising but limited results for specific groups, and they do not transfer to healthy people. Proper evidence not found, in the sources read, for CGM-guided eating improving clinical outcomes (such as heart disease or diabetes onset) in people without diabetes.

Frequently asked questions

Can I use a CGM to find my best diet?

No study read for this page shows that doing so improves long-term health in people without diabetes. Research shows responses vary between people. [2]

Is an over-the-counter CGM approved?

The FDA cleared one over-the-counter system in the US in 2024 for adults not using insulin; clearance covers that system and its stated use. [1]

Does a glucose spike mean I am unhealthy?

Not necessarily. Even people with normal standard tests had glucose variation in a CGM study, and the health meaning is unclear. [5]

Who should not rely on a CGM?

The FDA said the cleared system is not for people with problematic low blood sugar, because it is not designed to alert them. [1]

More details: evidence, limits and cautions

The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.

What regulators have said
On 5 March 2024 the US FDA cleared the first over-the-counter CGM, an integrated system for people 18 and older who do not use insulin, including adults without diabetes who want to understand how diet and exercise may affect blood sugar. [1] The FDA stated that the system is not for people with problematic low blood sugar because it is not designed to alert the user to it, and that users should not make medical decisions from the output without talking to their healthcare provider. [1] In the clinical study, reported adverse events included local infection, skin irritation and pain or discomfort. [1] This is a clearance of one named system in the United States, read 2026-10-22, not an endorsement of every CGM or app, and not proof that using one improves health. For devices and accuracy, see Nutrition Tracking and Continuous Glucose Monitors and Interstitial vs Blood Glucose.
Risks and limits
References
  1. US FDA, FDA Clears First Over-the-Counter Continuous Glucose Monitor (press announcement 2024-03-05). Read 2026-10-22.
  2. Zeevi et al., Cell 2015, Personalized Nutrition by Prediction of Glycemic Responses. Read 2026-10-22 (abstract on PubMed).
  3. Berry et al., Nature Medicine 2020 (PREDICT 1), Human postprandial responses to food and potential for precision nutrition. Read 2026-10-22 (abstract on PubMed).
  4. Publisher Correction to Berry et al., Nature Medicine 2020. Read 2026-10-22 (abstract on PubMed).
  5. Hall et al., PLoS Biology 2018, Glucotypes reveal new patterns of glucose dysregulation. Read 2026-10-22 (abstract on PubMed).
  6. Ben-Yacov et al., Diabetes Care 2021, Personalized Postprandial Glucose Response-Targeting Diet Versus Mediterranean Diet for Glycemic Control in Prediabetes. Read 2026-10-22 (abstract on PubMed).
  7. Rein et al., BMC Medicine 2022, Effects of personalized diets by prediction of glycemic responses in newly diagnosed T2DM: randomized pilot trial. Read 2026-10-22 (abstract on PubMed).
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.